Tag Archives: California

My First Blog Entry: An Enlivened Biotech Industry and BIO International Convention

Scott Whitaker

While Washington, DC struggles with yet another round of cold temperatures, inside the halls of BIO, we have turned the heat up and are working hard to make many exciting changes to the 2014 BIO International Convention in SUNNY San Diego. It is more than just California dreaming – our team has been breaking a sweat responding to all of the early registrations for this year’s event (it is how they get into convention shape). Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

More than a Quarter of 2013 US-Based Biotech IPOs Call California Home

BIO CONVENTION LOGO_VERTICAL_D_CMYK

And of those 39 US-based biotech companies, five of them are from San Diego, highlighting the region’s growing importance as hub for the biotech and life science industries. According to a recently authored BIO article in the Union Tribune San Diego, there are several reasons at play for the strong public offerings – enactment of the JOBS Act, an eager investor market and increasing regulatory transparency resulting from PDUFA V. As powerful as the JOBS Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Ask CA Governor Brown To Sign SB 598

Jim-044

California’s Assembly and Senate have both overwhelmingly passed Senate Bill 598, legislation that creates a pathway for the substitution of interchangeable biologic medicines. Despite fierce opposition from insurance companies and large pharmacy chains, it is now on its way to the Governor’s desk. It’s critical for him to understand that this issue is one of the highest priorities for patients, healthcare providers and the life sciences industry. Senate Bill 598 is needed now to update Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , ,

State Legislation Needed For Substitution of Interchangeable Biologics

flu-syringe

A great deal of the media coverage relating to California’s Senate Bill 598  neglects to mention a key issue in the biosimilars debate. This bill – or legislation similar to it – is essential to allow for the eventual substitution of interchangeable biologic therapies in the state of California. State laws governing prescription drug substitution were written before the advent of biosimilars and do not take the complexity of biologics into account. California, along with Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

California Continues Responsible Support for Interchangeability of Biologic Drugs

State Capitol

Yesterday, California’s State Assembly Committee on Appropriations took another decisive step when they unanimously voted in support of the revised SB 598 by recommending it back to the full Assembly after minor modifications. This is another important step taken by the California State Legislature to ensure patients and physicians who are managing chronic conditions are made fully aware of which biologic drug is ultimately administered by the pharmacist. When battling a serious disease, patients, physicians Read More >

Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , ,